Literature DB >> 27367533

Refractive Regression and Changes in Central Corneal Thickness Three Years after Laser-Assisted Subepithelial Keratectomy for High Myopia in Eyes with Thin Corneas: A Retrospective Study.

Dan Fu1, Zhen-Yong Zhang2, Lin Wang1, Xing-Tao Zhou1,3, Zhi-Qiang Yu1,3.   

Abstract

This retrospective study aimed to explore refractive regression and central corneal thickness (CCT) following laser-assisted subepithelial keratectomy (LASEK) performed for the correction of high myopia in eyes with thin corneas. Forty patients (19 male, 21 female; mean age, 28.5 years) representing 76 treated eyes were included. The mean optical zone was 6.10 ± 0.32 mm, and the mean ablation depth was 121.53 ± 15.48 µm. CCT was significantly greater three years after surgery than at three months after surgery (425.66 ± 15.44 vs. 385.20 ± 12.81, respectively; p<0.001). The mean change in CCT from three months to three years was 40.46 ± 14.02 µm. The SE at three years was greater than that at three months (p<0.001). Although there was refractive regression, these data suggest that LASEK may have utility in the correction of high myopia in eyes with thin corneas.

Entities:  

Keywords:  Central corneal thickness; LASEK; PRK; cornea; myopia; refractive regression

Mesh:

Year:  2016        PMID: 27367533     DOI: 10.3109/08820538.2016.1142579

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  2 in total

1.  A pilot study: LASEK with the Triple-A profile of a MEL 90 for mild and moderate myopia.

Authors:  Yingjun Chen; Dong Yang; Tian Han; Haipeng Xu; Meiyan Li; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2017-06-23       Impact factor: 2.209

2.  Long-Term Visual and Refractive Stability and Ocular Biometric Changes after Laser-Assisted Subepithelial Keratomileusis for Correction of Myopia: An 8-Year Follow-Up.

Authors:  Seyed Javad Hashemian; Acieh Es'haghi; Parya Abdolalizadeh; Leila Ghiasian; Hossein Aghaei; Mohammad Ebrahim Jafari; Mahsa Sadat Hashemian; Seyed Mahyar Hashemian
Journal:  J Curr Ophthalmol       Date:  2022-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.